Cargando…
Cardiac damage after treatment of childhood cancer: A long-term follow-up
BACKGROUND: With improved childhood cancer cure rate, long term sequelae are becoming an important factor of quality of life. Signs of cardiovascular disease are frequently found in long term survivors of cancer. Cardiac damage may be related to irradiation and chemotherapy. We have evaluated simult...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430718/ https://www.ncbi.nlm.nih.gov/pubmed/18492236 http://dx.doi.org/10.1186/1471-2407-8-141 |
_version_ | 1782156425246539776 |
---|---|
author | Velensek, Veronika Mazic, Uros Krzisnik, Ciril Demšar, Damjan Jazbec, Janez Jereb, Berta |
author_facet | Velensek, Veronika Mazic, Uros Krzisnik, Ciril Demšar, Damjan Jazbec, Janez Jereb, Berta |
author_sort | Velensek, Veronika |
collection | PubMed |
description | BACKGROUND: With improved childhood cancer cure rate, long term sequelae are becoming an important factor of quality of life. Signs of cardiovascular disease are frequently found in long term survivors of cancer. Cardiac damage may be related to irradiation and chemotherapy. We have evaluated simultaneous influence of a series of independent variables on the late cardiac damage in childhood cancer survivors in Slovenia and identified groups at the highest risk. METHODS: 211 long-term survivors of different childhood cancers, at least five years after treatment were included in the study. The evaluation included history, physical examination, electrocardiograpy, exercise testing and echocardiograpy. For analysis of risk factors, beside univariate analysis, multivariate classification tree analysis statistical method was used. RESULTS AND CONCLUSION: Patients treated latest, from 1989–98 are at highest risk for any injury to the heart (73%). Among those treated earlier are at the highest risk those with Hodgkin's disease treated with irradiation above 30 Gy and those treated for sarcoma. Among specific forms of injury, patients treated with radiation to the heart area are at highest risk of injury to the valves. Patients treated with large doses of anthracyclines or concomitantly with anthracyclines and alkylating agents are at highest risk of systolic function defect and enlarged heart chambers. Those treated with anthracyclines are at highest risk of diastolic function defect. The time period of the patient's treatment is emerged as an important risk factor for injury of the heart. |
format | Text |
id | pubmed-2430718 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-24307182008-06-19 Cardiac damage after treatment of childhood cancer: A long-term follow-up Velensek, Veronika Mazic, Uros Krzisnik, Ciril Demšar, Damjan Jazbec, Janez Jereb, Berta BMC Cancer Research Article BACKGROUND: With improved childhood cancer cure rate, long term sequelae are becoming an important factor of quality of life. Signs of cardiovascular disease are frequently found in long term survivors of cancer. Cardiac damage may be related to irradiation and chemotherapy. We have evaluated simultaneous influence of a series of independent variables on the late cardiac damage in childhood cancer survivors in Slovenia and identified groups at the highest risk. METHODS: 211 long-term survivors of different childhood cancers, at least five years after treatment were included in the study. The evaluation included history, physical examination, electrocardiograpy, exercise testing and echocardiograpy. For analysis of risk factors, beside univariate analysis, multivariate classification tree analysis statistical method was used. RESULTS AND CONCLUSION: Patients treated latest, from 1989–98 are at highest risk for any injury to the heart (73%). Among those treated earlier are at the highest risk those with Hodgkin's disease treated with irradiation above 30 Gy and those treated for sarcoma. Among specific forms of injury, patients treated with radiation to the heart area are at highest risk of injury to the valves. Patients treated with large doses of anthracyclines or concomitantly with anthracyclines and alkylating agents are at highest risk of systolic function defect and enlarged heart chambers. Those treated with anthracyclines are at highest risk of diastolic function defect. The time period of the patient's treatment is emerged as an important risk factor for injury of the heart. BioMed Central 2008-05-20 /pmc/articles/PMC2430718/ /pubmed/18492236 http://dx.doi.org/10.1186/1471-2407-8-141 Text en Copyright © 2008 Velensek et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Velensek, Veronika Mazic, Uros Krzisnik, Ciril Demšar, Damjan Jazbec, Janez Jereb, Berta Cardiac damage after treatment of childhood cancer: A long-term follow-up |
title | Cardiac damage after treatment of childhood cancer: A long-term follow-up |
title_full | Cardiac damage after treatment of childhood cancer: A long-term follow-up |
title_fullStr | Cardiac damage after treatment of childhood cancer: A long-term follow-up |
title_full_unstemmed | Cardiac damage after treatment of childhood cancer: A long-term follow-up |
title_short | Cardiac damage after treatment of childhood cancer: A long-term follow-up |
title_sort | cardiac damage after treatment of childhood cancer: a long-term follow-up |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430718/ https://www.ncbi.nlm.nih.gov/pubmed/18492236 http://dx.doi.org/10.1186/1471-2407-8-141 |
work_keys_str_mv | AT velensekveronika cardiacdamageaftertreatmentofchildhoodcanceralongtermfollowup AT mazicuros cardiacdamageaftertreatmentofchildhoodcanceralongtermfollowup AT krzisnikciril cardiacdamageaftertreatmentofchildhoodcanceralongtermfollowup AT demsardamjan cardiacdamageaftertreatmentofchildhoodcanceralongtermfollowup AT jazbecjanez cardiacdamageaftertreatmentofchildhoodcanceralongtermfollowup AT jerebberta cardiacdamageaftertreatmentofchildhoodcanceralongtermfollowup |